This topic contains a solution. Click here to go to the answer

Author Question: Although both the Larry P. V. Riles case and PASE v. Hannon cases dealt with overrepresentation of ... (Read 54 times)

Yolanda

  • Hero Member
  • *****
  • Posts: 757
Although both the Larry P. V. Riles case and PASE v. Hannon cases dealt with overrepresentation of minority children in special education due to a bias in intelligence testing used for eligibility the outcomes were different. Compare the two different outcomes to one another.
 
  What will be an ideal response?

Question 2

Vibro-tactile hearing aids are the most common hearing aids for children.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bobsmith

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

Answers should include:
Larry P. v. RilesIntelligence tests are biased, can't use to identify African American children as cognitively disabled, reduce the minority overrepresentation PASE v HannonIntelligence tests are not biased because they represent the culture of the schools, focused on SES differences that contributed to differences in performance

Answer to Question 2

False





 

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library